XLH UK

What XLH UK does

XLH UK is a patient-led charity registered in England and Wales (Charity number 1196811), founded in 2021 and headquartered in Kington, United Kingdom. It is the only UK-dedicated organization focused on X-linked hypophosphataemia (XLH) and related phosphate-wasting disorders, serving individuals diagnosed with the condition, their families, treating clinicians, and researchers studying rare bone disease.

The charity's core offerings are delivered through a WordPress-based website (xlhuk.org) and an in-person events program rather than a traditional technology product stack. Core services include disease and treatment information (with a specific educational track on burosumab, including the pre-filled syringe rollout), an XLH Connect peer-to-peer support program, a specialist finder tool, the downloadable XLH Library of clinical recommendations and research publications, and facilitated participation in the University of Oxford-led RUDY Study, which collects patient-reported outcomes on XLH symptoms, medicines, and quality of life.

XLH UK is funded through donations, individual fundraising campaigns (including half-marathon participation on platforms such as JustGiving), and grants such as the National Lottery Community Fund award received in 2025 to support Community Day events. The organization has 1-10 employees and operates without commercial pricing, relying on community engagement, social media (Facebook, Twitter/X, Instagram, YouTube with 1.1K+ subscribers), newsletters, and earned media to reach patients and supporters. In 2025 it received a Highly Commended recognition from the Market Research Society in the MRS/ICG Independent Consultants category for patient-story-led advocacy supporting NHS access to burosumab for adults.

Name

XLH UK

Legal name

XLH UK

Website

https://xlhuk.org

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

XLH UK is a patient-led UK charity supporting individuals and families affected by X-linked hypophosphataemia and related phosphate-wasting disorders through education, peer support, research participation, and NHS access advocacy.

Ownership category

akta.pro rank

Headquarters

HQ city

Kington

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Distribution channels1 record

Marketing channels6 records

Core offering

XLH UK is a patient-led registered charity that supports individuals and families affected by X-linked hypophosphataemia (XLH) and related phosphate-wasting disorders in the United Kingdom. It delivers disease information, treatment guidance (including burosumab), peer-to-peer support through XLH Connect, a specialist finder, community events, and facilitates participation in the University of Oxford RUDY Study. Funding comes from donations, individual fundraising, and grants such as the National Lottery Community Fund.

Product overview

XLH UK operates as a patient advocacy and support charity offering a unified platform of services rather than a traditional product. The core offering includes patient support resources covering disease information, treatment guidance, and peer support through XLH Connect. The organization also facilitates participation in the RUDY Study for research purposes and provides an XLH Library of downloadable clinical resources and research publications. The charity focuses on community support, raising awareness, and improving care for those affected by X-linked hypophosphataemia and related disorders.

Differentiator

Problem solved

Functional benefit

Products and services

• XLH UK Patient Support and Information Resources Comprehensive support platform providing information, resources, and community support for individuals and families affected by X-linked hypophosphataemia, including guidance on symptoms, dental health, physical and mental health, family planning, and treatment options.
• XLH Connect (Peer to Peer Support) Peer-to-peer support program connecting individuals and families affected by XLH to share experiences and provide mutual support.
• XLH UK Community Events (Community Day and Regional Family Days) In-person events bringing together the UK XLH community, including an annual Community Day conference in Birmingham, regional family days, and participation in Rare Disease Day activities.
• XLH Library Resource repository containing downloadable clinical practice recommendations, information leaflets, research publications, and consensus statements about XLH.
• RUDY Study (Patient-Reported Outcomes Research Partnership) A rare disease research study led by Oxford University that collects patient-reported data on XLH symptoms, treatment experiences, and quality of life to advance understanding and improve care.
• Find a Specialist Directory tool that helps XLH patients and families locate healthcare specialists experienced in diagnosing and treating X-linked hypophosphataemia in the UK.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core and minor.

• University of Oxford (RUDY Study)coreStrategic or Co-development PartnerThe RUDY Study is headed by a research team at the University of Oxford. It invites people with XLH and their caregivers to participate by completing questionnaires about symptoms, medicines, and daily life. The study collects data to strengthen the case for burosumab treatment and map UK availability, helping researchers understand XLH better.
• International XLH Alliance (IXLHA)coreStrategic or Co-development PartnerXLH UK participates in the International XLH Alliance, which coordinates global XLH community efforts including awareness campaigns like Rare Disease Day selfie collages and sharing of best practices across countries.
• Agency For GoodminorOthers

Recent moves6 records

Expansion highlights4 records

Regional players

• Metabolic Support UK: UK charity supporting patients and families affected by inherited metabolic disorders, including rare bone and mineral conditions. Overlap with XLH UK on rare metabolic patient support, specialist finder resources, and community events.
• Brittle Bone Society: UK charity supporting people with osteogenesis imperfecta and other rare bone conditions. Comparable UK-based rare bone disease advocacy, peer support, and information resource model.
• Rare Diseases UK: UK-wide campaign coalition for people with rare diseases and all who support them. Comparable UK rare-disease advocacy, awareness events (Rare Disease Day), and policy engagement function.
• Genetic Alliance UK: UK umbrella organization for over 200 patient groups supporting people with genetic, rare, and undiagnosed conditions. Comparable peer-support and policy advocacy model focused on rare conditions in the UK.

Emerging players

• Soft Bones (Hypophosphatasia Foundation): Patient advocacy organization for hypophosphatasia, another rare phosphate-wasting metabolic bone disease. Comparable mission (rare metabolic bone disease patient support, awareness, research engagement) and similar scale.
• The Magic Foundation: US charity supporting families affected by a range of rare endocrine and growth conditions, including XLH and related disorders. Comparable niche patient-education and peer-support model for rare metabolic conditions.

Broad incumbents

• EURORDIS - Rare Diseases Europe: European-level alliance representing over 1,000 rare disease patient organizations. Comparable advocacy and community-building role but at significantly larger scale and broader disease scope than XLH UK.
• National Organization for Rare Disorders (NORD): US-based umbrella organization for rare disease patient groups with a comparable mission of patient support, research, and advocacy. Much larger scale but operates the same model of rare-disease community empowerment.

Direct peers

• International XLH Alliance (IXLHA): Global coalition of XLH patient organizations of which XLH UK is a member. Coordinates cross-country awareness, shares best practices, and represents the XLH community internationally.
• XLH Network: US-based patient advocacy organization dedicated to X-linked hypophosphataemia. Most directly comparable peer; serves the same disease community, runs peer support and educational resources, and engages on treatment access advocacy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/ukxlh?lang=en
• YouTubeyoutube.com/channel/UCJB__sD9eO4mBsmwY8ev8iw
• Facebookfacebook.com/xlhuk
• LinkedInlinkedin.com/company/xlh-uk
• Instagraminstagram.com/xlh_uk

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about XLH UK